Bradley Merrill Thompson, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, authored an article in Law360, titled “A Topic-Based Analysis of FDA Responses to FOIA Requests.”
Following is an excerpt (see below to download the full article in PDF format):
In today's environment filled with misinformation, it is especially important for businesses to critically understand regulatory processes such as those of the U.S. Food and Drug Administration. For that reason, the Freedom of Information Act process should be fair and efficient.
Previously, I discussed my journey to analyze FOIA data on all the requests made over a 10-year period. As I continue to analyze the 118,000 requests in this article, I focus on my method using topic modeling, an analysis of response time outcomes by topic including which topics succeed and which do not.